THE HIGH PREVALENCE OF GENITAL HERPES AMONG PATIENTS WITH GENITAL ULCER DISEASE IN UGANDA

被引:35
作者
KAMYA, MR
NSUBUGA, P
GRANT, RM
HELLMAN, N
机构
[1] MAKERERE UNIV,SCH MED,DEPT MED,KAMPALA,UGANDA
[2] MAKERERE UNIV,UCSF COLLABORAT HLTH PROJECT,KAMPALA,UGANDA
关键词
D O I
10.1097/00007435-199511000-00006
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Genital ulcer disease is a risk factor for transmission of human immunodeficiency virus. One-hundred consecutive Ugandan patients (median age, 25 years) with genital ulcer disease were examined to determine the prevalence of genital herpes and its relationship to human immunodeficiency virus seropositivity. Goal of this Study. To improve management, prevention, and control of genital ulcer disease, thus reducing human immunodeficiency virus infections attributable to genital ulcer disease. Study Design: This was a prevalence study of genital herpes in a consecutive sample of an urban sexually transmitted disease clinic population. Results: Forty-nine percent (48/98) of the patients had genital herpes (36% by direct fluorescent antigen and 13% by history of recurrent vesicles). There was a trend toward larger lesions in patients who were human immunodeficiency virus seropositive. Twelve percent (11/89) of patients had syphilis, and 30% (30/100) remained sexually active, despite the presence of active genital ulcer disease. Sixty-five percent of 89 patients tested had antibodies to human immunodeficiency virus. Conclusions: Genital herpes is a common cause of genital ulcer disease in patients attending sexually transmitted disease clinics in Uganda, and herpes ulcers may be more extensive among those who are infected with human immunodeficiency virus.
引用
收藏
页码:351 / 354
页数:4
相关论文
共 13 条
[1]   THE ETIOLOGY OF GENITAL ULCERATION IN RWANDA [J].
BOGAERTS, J ;
RICART, CA ;
VANDYCK, E ;
PIOT, P .
SEXUALLY TRANSMITTED DISEASES, 1989, 16 (03) :123-126
[2]  
CAMERON DW, 1989, LANCET, V2, P403
[3]  
GOODGAME RW, 1990, NEW ENGL J MED, V323, P838
[4]   GENITAL ULCERATION AS A RISK FACTOR FOR HUMAN IMMUNODEFICIENCY VIRUS-INFECTION [J].
GREENBLATT, RM ;
LUKEHART, SA ;
PLUMMER, FA ;
QUINN, TC ;
CRITCHLOW, CW ;
ASHLEY, RL ;
DCOSTA, LJ ;
NDINYAACHOLA, JO ;
COREY, L ;
RONALD, AR ;
HOLMES, KK .
AIDS, 1988, 2 (01) :47-50
[5]  
LATIF AS, 1989, AIDS, V3, P519, DOI 10.1097/00002030-198908000-00006
[6]  
LOMHOLT G, 1972, UGANDA MED J, V1, P109
[7]  
MULDER DW, 1992, RES PROGRAMME AIDS U
[8]  
NSANZE H, 1981, BRIT J VENER DIS, V57, P378
[9]  
NSUBUGA P, 1990, J ACQ IMMUN DEF SYND, V3, P1002
[10]  
OFARRELL N, 1991, GENITOURIN MED, V67, P322